847 filings
8-K
ADXS
Ayala Pharmaceuticals, Inc.
20 Dec 19
Advaxis Reports Fiscal Year 2019 Financial Results and Provides a Business Update
4:31pm
10-K
2019 FY
ADXS
Ayala Pharmaceuticals, Inc.
Annual report
20 Dec 19
4:03pm
4
Gutierrez Andres
25 Oct 19
Advaxis / Andres Gutierrez ownership change
4:31pm
4
Berman Richard J
25 Oct 19
Advaxis / RICHARD J BERMAN ownership change
4:31pm
4
Sidransky David
25 Oct 19
Advaxis / DAVID SIDRANSKY ownership change
4:30pm
4
t9sqd h2ewpbhx3f
25 Oct 19
Advaxis / Molly Henderson ownership change
4:30pm
4
jq6oh5 qpv
25 Oct 19
Advaxis / RONI APPEL ownership change
4:30pm
4
jpmidcmu
25 Oct 19
Advaxis / Samir N Khleif ownership change
4:30pm
4
6n5n1pq
25 Oct 19
Advaxis / JAMES P PATTON ownership change
4:30pm
4
uwt4lebc4f7 7ne4
25 Oct 19
Advaxis / Kenneth A Berlin ownership change
4:30pm
8-K
b18ebgruesgx 0qy4z
25 Oct 19
Advaxis Announces Business and Pipeline Update
12:00am
8-K
1r3f8ahuqzr4x ooa554
4 Oct 19
Other Events
4:31pm
8-K
02fr97cce1e4b65
13 Sep 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
nckqmjfxfk2hsdo97og
9 Sep 19
Advaxis Reports Fiscal Third Quarter 2019 Financial Results and Provides Pipeline Update
4:30pm
8-K
97qwpaj6ya 85i2
6 Sep 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
vzpvob 0ot8ix9y
22 Aug 19
Advaxis, Inc. Issues Letter to Shareholders
4:15pm
8-K
xqw5m
31 Jul 19
Material Modifications to Rights of Security Holders
4:15pm
SC 13G
fsge2is500zc kolq
31 Jul 19
Advaxis, Inc.
1:33pm
8-K
vq0cao lz
25 Jul 19
Advaxis, Inc. Announces Pricing of $16 Million Public Offering
5:19pm